Latest findings from the breast cancer cohort in SUMMIT - A phase 2 'basket' trial of neratinib + trastuzumab + fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer Meeting Abstract
| Authors: | Jhaveri, K.; Saura, C.; Guerrero-Zotano, A.; Spanggaard, I.; Bidard, F. C.; Goldman, J. W.; Garcia-Sáenz, J. A.; Cervantes, A.; Boni, V.; Crown, J.; Brufsky, A.; Loi, S.; Haley, B.; Mayer, I. A.; Chia, S.; Lu, J.; Waisman, J.; Ben-Baruch, N. E.; Burkard, M. E.; Suga, J. M.; González-Cortijo, L.; Perrucci, B.; Xu, F.; Wong, S.; Zhang, J.; Eli, L. D.; Lalani, A. S.; Wildiers, H. |
| Abstract Title: | Latest findings from the breast cancer cohort in SUMMIT - A phase 2 'basket' trial of neratinib + trastuzumab + fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700127 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-PD1-05 |
| Notes: | Meeting Abstract: PD1-05 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
